Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

There are many possible causes for acute encephalitis, and systemic causes can be easily overlooked. We report a woman with initial status epilepticus, marked working memory impairment and ataxia, which developed 1 week following the ChAdOx1 SARS-CoV-2 (Astra-Zeneca) vaccination. Although lumbar puncture detected a paraprotein, it was not until she developed the hallmark cutaneous features of scleromyxoedema several months later that we recognised this as the dermato-neuro syndrome. Given the temporal association, the SARS-CoV-2 vaccination was a likely trigger, and the decision whether to give subsequent vaccinations during the heat of the COVID-19 pandemic added a layer of complexity to decision making. We review the literature regarding dermato-neuro syndrome in the setting of SARS-CoV-2 vaccination and explore its unique features.

More information Original publication

DOI

10.1136/pn-2025-004613

Type

Journal article

Publication Date

2026-01-13T00:00:00+00:00

Volume

26

Pages

51 - 54

Total pages

3

Keywords

CLINICAL NEUROLOGY, DERMATOLOGY, EPILEPSY, HAEMATOLOGY, PARAPROTEINAEMIA, Humans, Female, COVID-19, COVID-19 Vaccines, ChAdOx1 nCoV-19, Middle Aged, Vaccination, Nervous System Diseases, Skin Diseases